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ABSTRACT: 
PURPOSE:  The utility of measuring the pediatric adjusted shock index (SIPA) at admission for 
predicting severity of blunt injury in pediatric patients has been previously reported.  However, the 
utility of following SIPA after admission is not well described.   
METHODS:  The trauma registry from a level-one pediatric trauma center was queried from January 
1, 2010 to December 31, 2015.  Patients were included if they were between 4-16 years old at the 
time of admission, sustained a blunt injury with an Injury Severity Score >15, and were admitted less 
than 12 hours after their injury (n=286).  Each patient’s SIPA was then calculated at 0, 12, 24, 36, 
and 48 hours (h) after admission and then categorized as elevated or normal at each time frame 
based upon previously reported values.  Trends in outcome variables as a function of time from 
admission for patients with an abnormal SIPA to normalize as well as patients with a normal 
admission SIPA to abnormal were analyzed. 
RESULTS:  In patients with a normal SIPA at arrival, 18.4% of patients who developed an elevated 
SIPA at 12h after admission died, whereas 2.4% of patients who maintained a normal SIPA 
throughout the first 48h of admission died (p<0.01). Among patients with an elevated SIPA at arrival, 
increased length of time to normalize SIPA correlated with increased length of stay (LOS) and 
intensive care unit (ICU) LOS.  Similarly, elevation of SIPA after arrival in patients with a normal 
initial SIPA correlated to increased LOS and ICU LOS.   
CONCLUSIONS:  Patients with a normal SIPA at time of arrival who then have an elevated SIPA in 
the first 24h of admission are at increased risk for morbidity and mortality compared to those whose 
SIPA remains normal throughout the first 48h of admission.  Similarly, time to normalize an elevated 
admission SIPA appears to directly correlate with LOS, ICU LOS, and other markers of morbidity 
across a mixed blunt trauma population.  Whether trending SIPA early in the hospital course serves 
only as a marker for injury severity or if it has utility as a resuscitation metric has not yet been 
determined.   
KEYWORDS: Pediatric, SIPA, Shock Index, Trauma, Injury 
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INTRODUCTION 
 The shock index (SI), defined as heart rate (HR: beats per minute) divided by systolic blood 
pressure (SBP: in mmHg) was initially described by Allgower and Buri in 1967 [1]. Within the adult 
population a normal SI ranges from 0.5-0.7 and a SI >0.9 has been considered a “break point” for 
increased severity of illness [2-4].  The use of SI has been studied the most within the adult trauma 
population.  Elevation of SI at the time of arrival in the emergency department (ED) following 
polytrauma has been shown to predict need for massive transfusion, intensive care admission, and 
mortality [4-6]. Additionally, a persistently elevated SI, either pre-hospital to ED or ED to admission, 
has been shown to predict mortality [2, 3, 5]. 
 However, application of SI within the pediatric trauma population is difficult secondary to 
differences in HR and SBP in children as a function of age.  Recently Acker et al. have defined 
pediatric-adjusted SI (SIPA) values for children based upon vital signs across accepted age ranges 
and validated this model as a predictor for injury severity in blunt trauma [7].  Cutoff values for SIPA 
are as follows: 1.22 (ages 4-6 years), 1.0 (ages 7-12), and 0.9 (ages 13-16) with values above these 
cutoffs considered abnormal.  Since publication of this study, additional work has shown that SIPA 
has utility in identification of severe head injury, identification of severe isolated blunt liver/spleen 
injury, need for trauma team activation, and need for abdominal CT after blunt trauma injury [8-12]. 
 While validity for SIPA as an initial marker for injury severity has been established, the utility 
of following SIPA after admission has not been determined.  The purpose of this study was to 
determine if following trends in SIPA for the first 48 hours (h) in pediatric patients with severe blunt 
injuries correlated with morbidity and mortality. 
METHODS  
 In order to evaluate trending SIPA in a population where it has been validated, the 
inclusion/exclusion criteria created by Acker et al. were utilized [7].  The trauma registry from a 
single institution (Riley Hospital for Children at IU Health, Indianapolis, Indiana) was queried for all 
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patients sustaining blunt injuries with an injury severity score (ISS) of >15 from January 1, 2010 to 
December 31, 2015.  Children were excluded from the study cohort if they were less than 4 years 
old or greater than 16 years old.  Additionally, patients were excluded if they presented to our 
institution more than 12h after injury.  SIPA values were calculated for each patient at the time of 
arrival and every 12h thereafter until 48h after admission.  These scores were then categorized as 
either “elevated” (i.e. above normal SIPA score for age range) or normal.  Additionally, outcome 
variables related to SIPA previously reported by Acker et al. were reviewed along with demographic 
data (table 1) [7].  Measured outcome variables included: Intensive Care Unit (ICU) length of stay 
(LOS), total hospital LOS, days on mechanical ventilation, discharge to rehabilitation, blood 
transfusion within the first 24h of admission, and in-hospital mortality.  Patients were then 
categorized into two groups based upon their SIPA score at admission (i.e. elevated or not 
elevated).  Trends for outcomes for both groups at each subsequent 12-hour time interval based 
upon the presence or absence of an elevated SIPA were compiled. Chi-squared analysis and 
Kruskal-Wallis tests were performed when appropriate with a p-value <0.05 considered statistically 
significant.   
 Because the aggressiveness of resuscitation as well as ongoing bleeding after initial 
evaluation may contribute to alterations in SIPA over the study period, several common variables 
were analyzed.  The amount of packed red blood cells transfused (in mL/kg) and amount of 
intravenous crystalloid/colloid (“IVF”; in mL/kg) administered were calculated for the first 12h after 
admission, the second 12h after admission, and the first 24 hours of admission for all patients with 
available data over this period.  In a similar manner urine output (UOP; in mL/kg/h)  for the first and 
second 12h after admission were also calculated and reported as either less than or equal to/greater 
than 1mL/kg/h .  Hematocrit levels (in percentage) were also recorded.  These variables were then 
analyzed against trends in SIPA in a similar manner as previously discussed.  Other common 
variables such as serum lactate and base deficit were not drawn routinely enough for adequate 
statistical analysis in this study population.   
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RESULTS 
 During the study period, 286 patients were identified that met inclusion/exclusion criteria.  
Demographics and outcome variables for each age range were evaluated and there were no 
statistically significant differences between age groups (table 1).  Among these patients, 79 (27.6%) 
had an elevated SIPA at the time of arrival (table 1).  Additionally, among those children with a 
normal SIPA at arrival, 57 (19.9%) developed an elevated SIPA at 12h and/or 24h after admission.  
Trends in outcome variables previously mentioned for patients with elevated SIPA at arrival or those 
that developed an elevated SIPA after admission were evaluated.  P-values given include analyzed 
time points that were not included in the tables for simplicity. 
In-Hospital Mortality 
 Among patients with an elevated SIPA at the time of arrival, 19% of patients who normalized 
their SIPA within 12 hours died, whereas 31% of those that normalized in 13-24 hours of admission 
died and 29% of those who normalized between 25-36 hours of admission died (table 2; p-
value=0.152 for Fisher’s Exact Test; p-value=0.047 for Likelihood Ratio Chi-Square Test).  If a 
patient’s SIPA score was normal at arrival and remained normal throughout the first 48h of 
admission, 2.4% of these patients died.  In contrast, if a patient had a normal SIPA score at 
admission that was elevated at 12 hours, the mortality rate was 18.4% (table 2). Finally, if a patient 
had a normal SIPA at admission that was elevated at 24-hours or later (n=45), none of these 
patients died (p-value<0.01 for overall trend).  
Intensive Care Unit Length of Stay (ICU LOS) and Overall Hospital Length of Stay (LOS) 
 For patients with an elevated initial SIPA, there was an increased ICU LOS for patients as 
the time to normalize SIPA increased beyond 12 hours (table 3; p-value=0.032). Similarly, those 
patients who have a normal SIPA at arrival had longer ICU LOS if their SIPA elevated within the first 
36 hours of admission (p-value<0.001).  Similar trends were seen in overall hospital length of stay 
(table 3). 
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Total days of mechanical ventilation 
 In patients with an initial elevated SIPA, there was a positive correlation between total 
mechanical ventilation time and time to normalize SIPA (table 3; p-value=0.020). In patients who 
presented with a normal SIPA, there was no significant difference in the days on the ventilator 
between those who later had an elevated SIPA and those that did not. 
Received blood transfusion within 24 hours of admission 
 For patients with an elevated SIPA at arrival 29.7% of those that normalized their SIPA within 
12 hours of admission received a blood transfusion within 24 hours of admission, where 62.5% of 
those that required 13-24 hours to normalize their SIPA received blood (table 2; p-value 0.082).  For 
patients with a normal SIPA at arrival, 36.8% of those that had an elevated SIPA at 12 hours of 
admission underwent blood transfusion. 21.0% of patients with an elevated SIPA at 24 hours after 
admission and 11.3% of those patients with a normal SIPA throughout the first 48 hours of injury 
required blood transfusion, respectively (table 2; p-value=0.010).   
Discharge to In-patient Rehabilitation  
 For patients with an elevated SIPA at arrival 13.5% of those that normalized their SIPA within 
12 hours of admission required in-patient rehabilitation.  For those who required 13-24 hours to 
normalize their SIPA, 31.2% required in-patient rehabilitation (table 2; p-value=0.152).  For patients 
with a normal SIPA at arrival, 21.0% of those that had an elevated SIPA at 12 hours of admission 
required rehabilitation. 15.8% of patients with an elevated SIPA at 24 hours after admission and 
8.9% of those patients with a normal SIPA throughout the first 48 hours of injury required 
rehabilitation, respectively (table 2; p-value<0.001) 
Injury Severity Score (ISS) and Head Abbreviated Injury Score (Head AIS) 
 Within both subgroups analyzed, there were no statistically significant differences in ISS or 
Head AIS for patients as a function of trends in SIPA. 
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Resuscitation Metrics and Serial Hemoglobin Levels 
 In patients presenting with an elevated SIPA, there were no differences in total intravenous 
crystalloid/colloid (IVF) given, or transfused blood during the first 12h, second 12h, or first 24h after 
admission as a function of time to normalize their SIPA (tables 4&5).  Similarly, there were no 
differences in percentage of patients with UOP >1mL/kg/h as a function of time to normalize SIPA 
and serial hematocrit levels (tables 6&7). 
 In patients presenting with a normal SIPA, there were significant differences in patients with 
elevated SIPA at 12h and 24h with respect to IVF administered at all time ranges analyzed and total 
blood transfused within the first 24h (tables 8&9).  There were no differences in percentage of 
patients with UOP >1mL/kg/h and serial hematocrit levels (tables 10&11). 
 
DISCUSSION 
 SIPA is a useful tool in the initial assessment and triage of pediatric patients suffering from 
severe blunt injury.  To our knowledge, this study is the first to examine the utility of following the 
trends in SIPA after initial assessment with regard to important outcome metrics in the pediatric 
trauma population.  Trending a modified shock index within pediatric sepsis patients has yet to prove 
useful [13, 14].  Yasaka et al. examined utilizing a modified shock index for pediatric patients with 
septic shock using a different set of age ranges and cutoff values [14].  Within their study group, with 
the primary outcome measure of ICU mortality, there was no clear cutoff value that was predictive 
for mortality.  The authors state that their data, as well as several studies within the adult trauma 
population, suggest that persistent elevations in the shock index may represent areas of increased 
risk for mortality/need for aggressive resuscitation [3, 4, 14].  The pediatric trauma population is 
unique in as much that the initial insult (i.e. the traumatic injury) is well defined temporally whereas 
determining the “initial time” for a septic patient is not always clear.  Additionally, the utility of the 
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specific cutoff values for SIPA have be determined based upon previously accepted ranges for vital 
signs at different age and verified in multiple studies [7-12, 15, 16]. 
 Within this preliminary study, two groups of patients were analyzed; those that had an 
elevated SIPA upon arrival and those that did not but possibly developed an elevated SIPA within 
48h of admission.  This study cohort was created based upon inclusion/exclusion criteria previously 
used to create/verify SIPA within blunt pediatric trauma patients.  The trends in SIPA either 
normalizing from an initial abnormal value or becoming abnormal when initially normal were 
analyzed.   
 Among patients with an elevated/abnormal SIPA at arrival, the time to normalize SIPA had 
direct relation to ICU LOS, total LOS, and total days of mechanical ventilation.  It is important to note 
that reducing time to normalize an initially elevated SIPA did not ultimately show statistical 
significance for in-hospital mortality. However, other statistical models did reach significance.  This 
inconsistency may be clarified with a larger study population. However, the current data suggests 
that decreased time to normalize SIPA correlates with several factors for morbidity.   
 Among patients with an initially normal SIPA, patients who went on to develop an abnormal 
SIPA, particularly in the first 12h of admission, had significantly worse outcomes. These patients had 
greater in-hospital mortality, need for early blood transfusion, need for in-patient rehabilitation, ICU 
LOS, total LOS, and total days on mechanical ventilation. Thus, it appears that the progression from 
a normal SIPA to an abnormal SIPA is an important early warning sign for worse outcomes and may 
be a useful target in assessing patients’ clinical response to therapy.  After review of the study 
cohort, alterations in SIPA did not necessarily appear to correlate with ongoing bleeding after initial 
intervention/surgery as these events occurred in less than 5% of the study population, which 
prohibitied further statistical analysis.  Similarly, isolated traumatic brain/spine injuries and possible 
spinal shock occurred in less than 10% and 2% of the study cohort, respectively. 
 In order to determine if alterations in SIPA during the first 48h of admission were a function 
of level of resuscitation or ongoing bleeding, serial IVF, blood transfused, UOP, and hematocrit 
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levels were analyzed.  When analyzing the cohort with an elevated SIPA, there does not appear to 
be a difference in these metrics as a function of time to normalize SIPA, suggesting that either under 
resuscitation/ongoing bleeding did not occur frequently, its rate was homogenous across the study 
subsets, and/or the chosen metrics were not adequate.  Indeed, several commonly used 
resuscitation metrics (i.e. serum lactate levels and serum base deficit) were not obtained frequently 
enough to complete analysis and serves as a limitation to this study. 
 In patients with a normal SIPA at arrival, elevations in SIPA at 12h and 24h were associated 
with higher levels of IVF and transfusions, but no difference in rates of normal range UOP or 
hematocrit levels.  Interestingly, these subgroups were not associated with increased operative 
intervention for ongoing bleeding based upon individual patient chart review.  The nature of these 
elevations of SIPA after arrival are not completely understood at this time, but could represent a 
subgroup of patients requiring additional resuscitation, a marker for increased injury severity not 
appreciated by ISS or initial SIPA score.   
 Our study is not without limitation.  Due to the retrospective nature of this study, only 
correlations between trends in shock index and the measured outcome variables, resuscitation 
metrics, and serial hematocrit levels can be made.  Additionally, several common resuscitation 
metrics were not available for analysis within this retrospective study.  Ideally, the goal of trending 
SIPA would be to determine if intervention(s) that correct/keep SIPA within normal limits improve 
morbidity and mortality.  At this time, current data suggests that following SIPA beyond hospital 
admission serves as an additional marker for injury and helps with prognostication early in the 
hospital course.  Current ongoing research includes evaluating blunt trauma patients with lower ISS 
for trends in SIPA scores and outcomes.  
In a similar manner, sample size across the study period prohibited further in-depth analysis 
of SIPA within the specific age ranges.  Ideally, a larger study would allow analysis within the three 
age ranges to further determine if the magnitude of elevation in SIPA (or the rate in which it 
changes) correlate with outcomes, resuscitation metrics, and indices of ongoing bleeding.  A study of 
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this magnitude would likely require multi-institutional collaboration, and should be the next step in 
determining if there is additional value in following SIPA after admission beyond prognosis.   
CONCLUSION 
  Patients with a normal SIPA at time of arrival who then have an elevated SIPA in the first 
24h of admission are at increased risk for morbidity and mortality and had increased resuscitation 
metrics compared to those whose SIPA remains normal throughout the first 48h of admission.  
Similarly, time to normalize an elevated admission SIPA appears to directly correlate with LOS, ICU 
LOS, and other markers of morbidity across a mixed blunt trauma population.  Whether trending 
SIPA early in the hospital course serves only as a marker for injury severity or if it has utility as a 
resuscitation metric has not yet been determined. 
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Table 1. Demographics and Outcomes for Children By Age Group 
 Age 4-6 
(n= 66) 
Age 7-12 
(n= 134) 
Age 13-16 
(n= 86) 
p-value 
Male, n (%) 41 (62.1%) 85 (63.4%) 63 (73.3%) 0.269 
ISS, mean (SEM) 22.5 (0.9) 24.2 (0.8) 23.2 (0.9) 0.388 
Head AIS median (IQR) 4 (0-4) 4 (0-4) 3 (0-4) 0.381 
Elevated SIPA on Arrival, n (%) 12 (18.2%) 44 (32.8%) 23 (26.7%) 0.091 
ICU LOS (days) Median (IQR) 1.5 (0-3) 1 (0-3) 1 (1-4) 0.323 
Hospital LOS (days) Median (IQR) 5 (3-8) 4 (2-8) 4.5 (3-10) 0.284 
Mechanical Ventilation (days) Median (IQR) 0 (0-1) 0 (0-1) 0 (0-2) 0.558 
Discharge to Rehabilitation n, % 11 (16.7%) 24 (17.9%) 16 (18.6%) 0.683 
Blood transfusion in first 24 hours of Admission n, % 16 (24.2%) 33 (24.6%) 24 (27.9%) 0.098 
Ventilator Associated Pneumonia n, % 5 (7.6%) 8 (6.0%) 9 (10.5%) 0.560 
Urinary Tract Infection n, % 2 (3.0%) 4 (3.0%) 5 (5.8%) 0.882 
Surgical Site Infection n, % 0 (0%) 3 (2.2%) 2 (2.3%) 0.954 
Bacteremia n, % 0 (0%) 6 (4.5%) 4 (4.7%) 0.865 
All Infections n, % 7 (10.6%) 15 (11.2%) 16 (18.6%) 0.198 
Death prior to discharge n, % 5 (7.6%) 13 (9.7%) 6 (7.0%) 0.504 
ISS: Injury Severity Score; SEM: Standard Error of the Mean; IQR: Inter-quartile Range; AIS: Abbreviated Injury Score; LOS: Length of Stay 
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Table 2. Trends in SIPA for Binomial Outcome Variables 
 Elevated SIPA at arrival 
(n=79) 
Normal SIPA at Arrival  
(n=207) 
 Normalized 
by 12 hours 
(n=37) 
Normalized 
within 13-
24 hours 
(n=16) 
Always 
Normal 
SIPA 
(n=124) 
Elevated 
SIPA at 12 
hours 
(n=38) 
Elevated 
SIPA at 24 
hours 
(n=19) 
Death (n; %) 7 (18.9%) 5 (31.2%) 3 (2.4%) 7 (18.4%) 0 (0%) 
Survival to discharge (n; %) 30 (81.1%) 11 (68.8%) 121 (97.6%) 31 (81.6%) 19 (100%) 
p-value 0.152 <0.001 
      
Transfusion in first 24 
hours (n; %) 
11 (29.7%) 10 (62.5%) 14 (11.3%) 14 (36.8%) 4 (21.0%) 
No transfusion in first 24 
hours (n; %) 
26 (70.3%) 6 (37.5%) 110 (88.7) 24 (63.2%) 15 (78.0%) 
p-value 0.082  0.010 
      
Discharge to Rehabilitation 
(n; %) 
5 (13.5%) 5 (31.2%) 11 (8.9%) 8 (21.0%) 3 (15.8%) 
Rehabilitation not Needed 
(n; %) 
32 (86.5%) 11 (68.8%) 113 (91.1%) 30 (79.0%) 16 (84.2%) 
p-value 0.152 <0.001 
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Table 3. Trends in SIPA for Continuous Outcome Variables 
 Elevated SIPA at arrival (n=79) 
 Normalized 
by 12 
hours 
(n=37) 
Normalized 
by 13-24 
hours  
(n=16) 
Normalized 
by 25-36 
hours  
(n=7) 
Normalized 
by 37-48 
hours (n=7) 
Normalized 
after 48 
hours 
(n=12) 
ICU LOS  
(median days, (IQR)) 
2 (1-3) 2 (1-16) 4 (1-15) 7 (3-43) 10.5 (5-12) 
p-value 0.032 
        
LOS  
(median days, (IQR)) 
5 (1-7) 4.5 (1.5-19.5) 9 (1-21) 5 (3-13) 15 (9-20.5) 
p-value 0.018 
        
Total days on ventilator 
(median days, (IQR)) 
1 (1-2) 2 (1-5) 9 (1-9) 5 (2-32) 6.5 (4.5-9) 
p-value 0.020 
  
 Normal SIPA at Arrival (n=207) 
 Always 
Normal 
SIPA 
(n=124) 
Elevated 
SIPA at 12 
hours  
(n=38) 
Elevated 
SIPA at 24 
hours       
(n=19) 
ICU LOS  
(median days, (IQR)) 
2 (1-3) 2.5 (1-8) 3 (2-5) 
p-value <0.001 
    
LOS  
(median days, (IQR)) 
3 (2-5) 6 (4-12) 6 (4-10) 
p-value <0.001 
    
Total days on ventilator 
(median days, (IQR)) 
1.5 (1-6) 3 (1-9) 3 (1.5-8) 
p-value 0.205 
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Table 4. Comparison of IVF for Elevated SIPA at Arrival 
  IVF in first 12h  
(mL/kg (median (IQR)) 
IVF in second 12h  
(mL/kg (median (IQR) ) 
IVF in first 24h  
(mL/kg (median (IQR)) 
Normalized by 
12 hours 
37.6 (18.6-56.0) 26.7 (23.1-37.8) 74.7 (52.6-88.9) 
Normalized by 
24 hours 
42.9 (33.8-50.0) 22.8 (20.9-51.4) 67.0 (58.2-98.8) 
Normalized by 
36 hours 
81.9 (75.7-93.4) 39.7 (21.3-51.3) 133 (114.7-133.6) 
Normalized by 
48 hours 
36.2 (25.7-51.0) 30.4 (23.6-32.9) 70.3 (57.0-86.8) 
Normalized after 
48 hours 
56.6 (32.3-118.0) 42.7 (33.2-61.4) 11.0 (68.0-200.3) 
p-value 0.198 0.487 0.336 
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Table 5. Comparison of Blood Transfused for Elevated SIPA at Arrival 
  Blood in first 12h  
(mL/kg (median (IQR)) 
Blood in second 12h 
(mL/kg (median (IQR) ) 
Blood in first 24h  
(mL/kg (median (IQR)) 
Normalized by 
12 hours 
0 (0) 0 (0) 0 (0) 
Normalized by 
24 hours 
2.6 (0-8.5) 0 (0-7.2) 4.3 (0-17.3) 
Normalized by 
36 hours 
0 (0-5.4) 0 (0-6.1) 11.54 (0-19.0) 
Normalized by 
48 hours 
0 (0-10.6) 0(0) 8.4 (0-10.6) 
Normalized 
after 48 hours 
10.4 (0-20.8) 0 (0-1.6) 13.5 (0-26.7) 
p-value 0.095 0.083 0.068 
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Table 6. Comparison of Urine Output (UOP) for Elevated SIPA at Arrival 
  UOP first 12h  
(Percent of patients > 1mL/kg/h) 
UOP second 12h  
(Percent of patients > 1mL/kg/h) 
Normalized by 12 
hours 
50% 57% 
Normalized by 24 
hours 
85% 71% 
Normalized by 36 
hours 
60% 80% 
Normalized by 48 
hours 
80% 43% 
Normalized after 48 
hours 
82% 75% 
p-value 0.346 0.743 
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Table 7. Comparison of Hematocrit (Hct) for Elevated SIPA at Arrival 
Elevated 
at 12h 
33.8 (30.5-36.2) 33.0 (26.5-35.1) 30.5 (28.0-32.4) 
Elevated 
at 24h 
35.9 (28.0-38.8) 29.7 (26.1-34.0) 31.4 (30.8-36.0) 
Elevated 
at 36h 
30.9 (25.2-35.9) 32.0 (29.3-33.1) 29.6 (26.3-31.3) 
Elevated 
at 48h 
33.9 (28.9-35.6) 25.0 (22.7-33.7) 28.9 (25.9-29.0) 
Always 
Normal 
30.7 (28.8-34.8) 30.8 (30.0-32.5) 29.0 (27.2-32.6) 
p-value 0.667 0.877 0.578 
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Table 8. Comparison of IVF for Normal SIPA at Arrival 
  IVF in first 12h  
(mL/kg (median (IQR)) 
IVF in second 12h  
(mL/kg (median (IQR) ) 
IVF in first 24h  
(mL/kg (median (IQR)) 
Elevated 
at 12h 
39.5 (23.3-61.3) 28.5 (21.8-40.7) 72.3 (46.3-108.4) 
Elevated 
at 24h 
40.2 (25.9-61.0) 27.0 (17.1-32.6) 59.8 (51.4-86.6) 
Elevated 
at 36h 
30.6 (15.5-52.7) 26.0 (14.3-33.7) 55.6 (37.2-105.4) 
Elevated 
at 48h 
23.8 (16.4-37.2) 26.3 (21.7-29.6) 48.9 (44.2-58.4) 
Always 
Normal 
23.9 (16.0-39.2) 22.3 (16.9-29.2) 47.7 (46.6-64.2) 
p-value 0.003 0.050 0.002 
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Table 9. Comparison of Blood Transfused for Normal SIPA at Arrival 
  Blood in first 12h  
(mL/kg (median (IQR)) 
Blood in second 12h  
(mL/kg (median (IQR)) 
Blood in first 24h  
(mL/kg (median (IQR)) 
Elevated 
at 12h 
0 (0-2.9) 0 (0) 0 (0-6.9) 
Elevated 
at 24h 
0 (0) 0 (0) 0 (0) 
Elevated 
at 36h 
0 (0) 0 (0) 0 (0) 
Elevated 
at 48h 
0 (0) 0 (0) 0 (0) 
Always 
Normal 
0 (0) 0 (0) 0 (0) 
p-value 0.057 0.162 0.011 
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Table 10. Comparison of Urine Output (UOP) for Normal SIPA at Arrival 
  UOP first 12h  
(Percent of patients > 1mL/kg/h) 
UOP second 12h  
(Percent patients > 1mL/kg/h) 
Elevated at 12h 76% 84% 
Elevated at 24h 78% 58% 
Elevated at 36h 98% 90% 
Elevated at 48h 45% 67% 
Always Normal 68% 73% 
p-value 0.324 0.289 
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Table 11. Comparison of Hematocrit (Hct) for Normal SIPA at Arrival 
  Hct at arrival  
(Percent (median (IQR)) 
Hct 12h after arrival  
(Percent (median (IQR)) 
Hct 24h after arrival  
(Percent (median (IQR)) 
Elevated 
at 12h 
34.4 (31.4-36.9) 29.6 (27.7-33.5) 27.7 (25.5-30.2) 
Elevated 
at 24h 
34.8 (32.0-37.8) 30.0 (25.0-33.2) 28.3 (25.7-30.3) 
Elevated 
at 36h 
32.5 (31.1-35.3) 29.9 (29.0-32.5) 28.8 (25.8-32.0) 
Elevated 
at 48h 
36.6 (34.8-37.6) 33.8 (31.8-36.0) 29.2 (27.2-31.7) 
Always 
Normal 
36.0 (32.9-38.2) 32.1 (29.2-35.8) 30.2 (27.8-32.8) 
p-value 0.192 0.104 0.485 
 
 
